Clinical Trial Update: Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating a six-month high-dose rifampicin, high-dose isoniazid, linezolid, and pyrazinamide regimen versus a standard nine-month regimen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Meningitis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• Linezolid (Linezolid)
• Pyrazinamide (pyrazinamide)
• Rifampicin

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculous Meningitis | Phase 2 | Status: RECRUITING